KEI Briefing Note
Contracts that Restrict Patent Filing or Impose Patent-Licensing Obligations
Contracts that restrict patent filing or impose patent-licensing obligations This briefing note illustrates examples of contractual language from data-sharing agreements and material transfer agreements that limit patent filing or impose specific licensing terms. KEI Briefing Note 2025:4 Arianna Schouten December… Continue Reading
Note on Liability Rules
Selected Documents Prepared by the WIPO Secretariat for the Intergovernmental Committee (IGC) on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore
KEI Comments on NIH Proposal to Require License Holders to Provide Access Plans
KEI Comments to CMS Regarding Imbruvica (INN:Ibrutinib) R&D (regarding Medicare pricing negotiations)
On October 2, 2023, Knowledge Ecology International submitted written comments to the Centers for Medicare & Medicaid Services (CMS) in conjunction with the Medicare Price Negotiation public consultation process. CMS is hosting a series of patient-focused listening sessions this fall,… Continue Reading
KEI Notes on the Clinical Studies for Imbruvica (Ibrutinib)
Notes on the Preclinical Development of Imbruvica (Ibrutinib)
Mismatch between the Cost to Perform Pediatric Extension Trials and the Cost to the Public of the FDA PED Monopoly Extension
KEI Comment on the Reduction of Number of Days the Public Can Comment on a Prospective NIH Exclusive Patent License
The National Institute of Health (NIH) recently held an all-day workshop titled, “Transforming Discoveries Into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer.” KEI Director James Love participated in the July 31st workshop, speaking on the panel on “How NIH… Continue Reading